Home / Community / News / News

News

11/06/2018 - 6:17am

An innate immune response pathway, the induction of interferon type 1, rather than activation of autophagy, is responsible for impaired myogenesis in CDM.

11/01/2018 - 6:23am

A literature review suggests meta-analysis of cognitive studies in DM1 is both feasible and can inform understanding of disease mechanisms and patient management.

10/16/2018 - 8:26am

A new study lends support for a DM biomarker panel based upon patient urine exRNA assays that may serve as a pharmacodynamic biomarker for go/no go decisions in drug development for DM1.

10/16/2018 - 8:19am

A new review looks at the cross-disease evidence for RAN translation’s contributions to pathogenesis.

09/25/2018 - 12:03pm

MDF is pleased to announce the publication of the first-ever Consensus-based Care Recommendations for Adults with Myotonic Dystrophy Type 1.

Partners

ExpansionTherapeutics.png

© Myotonic Dystrophy Foundation. All rights reserved.